29
Participants
Start Date
October 25, 2023
Primary Completion Date
October 30, 2026
Study Completion Date
October 30, 2026
ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin
RC48-ADC combined with hypofractionated radiotherapy, PD-L1 inhibitor sequential GM- CSF and Thymopentin
Second Affiliated Hospital of Soochow University, Suzhou
Second Affiliated Hospital of Soochow University
OTHER